This site is intended for UK healthcare professionals only

Diabetes Professional Care
21-22 October 2025, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

Legal Notice

DIABETES PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR DIABETES PROFESSIONAL CARE CAN BE FOUND HERE.
 

News

Subpage Hero

     

24 Sep 2021

Calls for personalised treatment for people with type 2 diabetes and depression

Calls for personalised treatment for people with type 2 diabetes and depression

People with type 2 diabetes and depression are at greater risk of suffering complications and should receive targeted treatment, the authors of a new study have said.

A team of researchers in Italy and Canada found that depression in type 2 diabetes was associated with a 2.3-fold risk of developing acute complications, a 1.6-fold risk of developing long-term complications, and a 2.8-fold mortality risk.

They looked at more than 30,000 people with type 2 diabetes with no prior history of depression, from 2008 to 2017. The researchers found at a follow up in 2020 that just over 5,000 people – 16.7 per cent – developed depression.

Being female, older than 65, living in a rural area and having comorbid diseases were found to be predictors of depression.

Led by Paolo Di Bartolo from the Diabetes Unit at AUSL Romagna in Italy, the authors commented: ''Our findings highlight that depression is associated with an increased risk for complications in type 2 diabetes and mortality and should not be neglected. Therefore, it is important to promote screening activities and introduce targeted and personalised treatment for depression in order to reduce the risk of poor short and long-term outcomes of diabetes.''

Read the full story here.

View all News
Loading

Partners

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner